This present study as we depicted in our schematic abstract (Figure 6), demonstrated that aberrantly expressed PDK1 independently drives PI3K/AKT/mTOR oncogenic signaling, characterizes poorly differentiated cells, activates ALDH1 and is associated with the desensitization of aggressive hepatocellular carcinoma cells to radiotherapy. This evidence concerns the gene MTOR and hepatocellular carcinoma.